<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Environmental Health Engineering and Management Journal</title>
<title_fa>Environmental Health Engineering and Management Journal</title_fa>
<short_title>Environ. Health Eng. Manag.</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ehemj.com</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2423-3765</journal_id_issn>
<journal_id_issn_online>2423-4311</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>7</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>12</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2023</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<volume>10</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Screening of camphene as a potential inhibitor targeting SARSCoV-2 various structural and functional mutants: Through reverse docking approach</title>
	<subject_fa>تخصصي</subject_fa>
	<subject>Special</subject>
	<content_type_fa>مقاله اصیل</content_type_fa>
	<content_type>Original Article</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;Background: SARS-CoV was first identified in 2003 but SARS-CoV-2, which gained its recognition again in 2019 as COVID-19, has been a crucial threat worldwide and has caused more death rates than the SARS-CoV but till now no confined treatments are available. The present study aimed to investigate the efficacy of camphene against various structural and functional mutants of SARS-CoV-2 using reverse docking protocol.&lt;br&gt;
Methods: To investigate the efficacy of camphene as a potential antiviral drug against COVID-19, against of all possible target proteins in SARS-CoV-2, which could lead to a new platform for drug discovery. Reverse pharmacology (Reverse docking) approach was performed, which involved docking of camphene and 20 structural and non-structural proteins (NSPs) of SARS-CoV-2 performed using maestro 12.8 of Schr&amp;ouml;dinger.&lt;br&gt;
Results: The results were evaluated since the minimum binding energy obtained after docking and camphene was effective against most of the proteins responsible for SARS-CoV-2, but camphene showed greater efficacy against the main protease (protease 9), which is main functional protein of&lt;br&gt;
SARS-CoV-2. Hence, the study proves that camphene can be a good drug candidate for different mutants of SARS-CoV-2.&lt;br&gt;
Conclusion: Protease 9, which is the main functional protein of SARS-CoV-2, expressed the best binding affinity with camphene having the minimum binding energy (-5.616). Hence, it is concluded that camphene could be the drug contender against protease 9 as it is a more potent target in SARSCoV-2. This could be a major finding, as camphene is related to camphor, which is already very beneficial against many respiratory problems.&lt;br&gt;
&lt;br&gt;
&amp;nbsp;&lt;/div&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>SARS-CoV-2, Functional mutants, Reverse pharmacology, Binding affinity, Drug discovery</keyword>
	<start_page>123</start_page>
	<end_page>129</end_page>
	<web_url>http://ehemj.com/browse.php?a_code=A-10-1-298&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mahendra </first_name>
	<middle_name></middle_name>
	<last_name>Kumar Savita</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mks.kanpur1@gmail.com</email>
	<code>100319475328460013528</code>
	<orcid>100319475328460013528</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Naraina Vidyapeeth Engineering and Management Institute, Kanpur, UP, India -208020</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Neha </first_name>
	<middle_name></middle_name>
	<last_name>Bora</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>nehabora144@gmail.com</email>
	<code>100319475328460013529</code>
	<orcid>100319475328460013529</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Institute of Forensic Science and Criminology, Bundelkhand University, Jhansi, U.P. 284128, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Ruby </first_name>
	<middle_name></middle_name>
	<last_name>Singh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>rubys922@gmail.com</email>
	<code>100319475328460013530</code>
	<orcid>100319475328460013530</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Corresponding author: Crazy fox creation, Vineet Khand, Gomti Nagar, Lucknow, UP, India-226010</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Prachi </first_name>
	<middle_name></middle_name>
	<last_name>Srivastava</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>psrivastava@amity.edu</email>
	<code>100319475328460013531</code>
	<orcid>100319475328460013531</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow Campus 226028, India</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
